About SPORTIVO Network
0 Σχόλια
0 Μοιράστηκε
179 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Adalimumab Biosimilar Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Demand for Cost-Effective Biologic Therapies and Expanding Biosimilar AdoptionAccording to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30 million in 2022, is expected to reach USD 3431.48 million by 2030, at a CAGR of 24.4% during the forecast period 2023 to 2030. This Adalimumab Biosimilar Marketdocument provides with...0 Σχόλια 0 Μοιράστηκε 401 Views 0 Προεπισκόπηση
-
Antimicrobial Agent Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Infectious Diseases and Growing Demand for Advanced Healthcare SolutionsAccording to the latest report published by Data Bridge Market Research, the Antimicrobial Agent Market The global antimicrobial agent market size was valued at USD 3.66 billion in 2024 and is expected to reach USD 7.29 billion by 2032, at a CAGR of 9.00% during the forecast period Antimicrobial Agent Market report offers a thorough overview of product specification, technology,...0 Σχόλια 0 Μοιράστηκε 407 Views 0 Προεπισκόπηση
-
Biologic Medications for Psoriasis Market Expanding at 7.8% CAGR from 2026–2034 with Strong Industry AdoptionAccording to a new report from Intel Market Research, the global biologic medications for psoriasis market was valued at USD 14.5 billion in 2025 and is projected to reach USD 28.7 billion by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is fueled by increasing psoriasis prevalence, superior efficacy of biologics over conventional treatments, and...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Calcium Sulphate Market to Reach US$ 5.9 Billion by 2033, Growing at 5.31% CAGRWhat is Calcium Sulphate ? Calcium sulphate is a naturally occurring inorganic compound commonly known as gypsum in its hydrated form. It is widely valued for its binding properties, fire resistance, non-toxic nature, and versatility across multiple industries. Calcium sulphate is available in both natural and synthetic forms, with synthetic gypsum increasingly produced through Flue Gas...0 Σχόλια 0 Μοιράστηκε 267 Views 0 Προεπισκόπηση
-
Contraceptive Devices Industry Forecast: Market Expected to Grow to US$ 45.65 Billion by 2033What are Contraceptive Devices? Contraceptive devices are medical products designed to prevent pregnancy by blocking fertilization, inhibiting sperm from reaching the egg, or preventing implantation. These devices offer temporary or long-term birth control solutions and are widely used as part of family planning and reproductive health management. The global Contraceptive Devices...0 Σχόλια 0 Μοιράστηκε 213 Views 0 Προεπισκόπηση
-
Dyslipidemia Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Cardiovascular Diseases and Growing Demand for Lipid-Lowering TherapiesAccording to the latest report published by Data Bridge Market Research, the Dyslipidemia Market Data Bridge Market Research analyses that the global dyslipidemia market, which was USD 15.05 billion in 2022, and would rocket up to USD 22.09 billion by 2030, and is expected to undergo a CAGR of 5.00% during the forecast period. Dyslipidemia Market survey report is intended to help...0 Σχόλια 0 Μοιράστηκε 285 Views 0 Προεπισκόπηση
-
Generic Healthcare Pharmaceuticals Market Trends: Digital Medicine Access, AI Drug Production & Global Care ExpansionGeneric Healthcare Pharmaceuticals Market: Digital Medicine Access, AI Drug Manufacturing & Affordable Global Healthcare Growth (2025–2033) Written By Shubham Senior Pharmaceutical Innovation & Global Healthcare Analyst | M2Square ConsultancyExperience: 4+ Years Shubham is a pharmaceutical and healthcare market research analyst specializing in generic healthcare...0 Σχόλια 0 Μοιράστηκε 505 Views 0 Προεπισκόπηση
-
Global Altretamine Market to Reach USD 210 Million by 2034, Driven by Rising Ovarian Cancer Cases and Advancements in Oncology TherapiesAccording to new market intelligence from Intel Market Research, the global Altretamine market was valued at USD 120 million in 2024, with projections indicating steady growth to USD 210 million by 2034 at a CAGR of 5.8% during the forecast period (2026-2034). This expansion reflects increasing adoption in oncology treatment protocols, particularly for platinum-resistant ovarian cancer cases,...0 Σχόλια 0 Μοιράστηκε 628 Views 0 Προεπισκόπηση
-
Global Clinical Trial Services Market Trends 2026–2034: AI Healthcare Platforms and CRO DigitalizationContract Research Organization Market Advances Through Smart Healthcare Analytics and Remote Research Technologies Written By Shubham Senior Market Research Analyst Experience: 160+ Market Research Projects in Digital Healthcare, Biotechnology & Pharmaceutical Research Industries The global Contract Research Organization (CRO) Market was valued at USD 94.8 billion in 2026 and is...0 Σχόλια 0 Μοιράστηκε 523 Views 0 Προεπισκόπηση
-
Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032According to the latest report published by Data Bridge Market Research, the Hypoactive Sexual Desire Disorder Treatment Market Data Bridge Market Research analyses a growth rate in the hypoactive sexual desire disorder treatment market in the forecast period 2023-2030. The expected CAGR of hypoactive sexual desire disorder treatment market is tend to be around 4% in the mentioned...0 Σχόλια 0 Μοιράστηκε 346 Views 0 Προεπισκόπηση
-
Janus Kinases (JAKs) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Autoimmune Disorders and Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. This Janus Kinases (JAKs)...0 Σχόλια 0 Μοιράστηκε 346 Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων
Czech
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)